30.10
Real-Time Quote
 -0.095 / -0.31%
Today’s Change
27.76
Today|||52-Week Range
32.96
-1.75%
Year-to-Date
Consumer and pharma groups swap assets
2:03pm / FT.com
Pre-Open Stock Movers 7/23 (PBYI) (ISRG) (BIIB) Higher; (XNLX) (MEET) (XOOM) Lower (m...
Jul 23 / Investing Channel
Why Pfizer (PFE) Stock Is Lower Today
10:15am / TheStreet.com
Puma Biotechnology Inc's Overnight Triple is Just the Beginning
Jul 22 / MotleyFool.com
Is a Surprise Coming for Pfizer (PFE) This Earnings Season? - Tale of the Tape
9:38am / Zacks.com
After-Hours Stock Movers 7/22: (PBYI) (TLM) (ISRG) Higher; (XOOM) (XLNX) (AAPL) Lower...
Jul 22 / Investing Channel
Will This Analyst Downgrade Hurt Pfizer (PFE) Stock Today?
9:27am / TheStreet.com
Johnson & Johnson Announces $5B Share Buyback - Analyst Blog
Jul 22 / Zacks.com
Another Heavy Earnings Week on Tap, as Pfizer, UPS, 5 Others Set to Report
9:04am / TheStreet.com
Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
Jul 22 / Zacks.com
Navigating the Twitter Minefield
6:48am / TheStreet.com
Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal - Analyst Blog
Jul 22 / Zacks.com
Is the Q2 Earnings Improvement Sustainable? - Earnings Preview
Jul 25 / Zacks.com
Pfizer's Stock Falls Ill as the Dow Tumbles
Jul 21 / MotleyFool.com
Why Obama Has Attacked Cross-Border Mergers at This Particular Time
Jul 25 / TheStreet.com
ABBV, MRK And PFE, Pushing Health Care Sector Downward
Jul 21 / TheStreet.com
3 Stocks Reiterated As A Buy: PFE, OXY, ORCL
Jul 25 / TheStreet.com
3 Stocks Reiterated As A Buy: PFE, ORCL, PEP
Jul 21 / TheStreet.com
Shire, ArmaGen Ink Licensing Agreeement for AGT-182 - Analyst Blog
Jul 24 / Zacks.com
Bristol-Myers/Pfizer Commence Phase IV Study on Eliquis - Analyst Blog
Jul 18 / Zacks.com
Bristol-Myers (BMY) Beats on Q2 Earnings, Maintains Outlook - Analyst Blog
Jul 24 / Zacks.com
Technology: Wear your medicine
Jul 18 / FT.com
AmerisourceBergen Beats on Q3 Earnings & Revenues, Ups View - Analyst Blog
Jul 24 / Zacks.com
AstraZeneca unveils plans for B#330m R&D centre in Cambridge
Jul 18 / FT.com
Pfizer's Incoming Patent Cliff
Jul 24 / MotleyFool.com
Drugmaker in $54.7 billion merger aimed at cutting U.S. taxes
Jul 18 / CNNMoney.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 / Zacks.com
Eli Lilly and Immunocore Collaborate to Develop Cancer Drugs - Analyst Blog
Jul 17 / Zacks.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 / Zacks.com
Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz - Analyst Blog
Jul 17 / Zacks.com
Healthcare Spending to Trend Up in 2015: 3 Healthcare Fund Picks - Best of Funds
Jul 24 / Zacks.com
AbbVie set to unveil B#31bn Shire takeover
Jul 17 / FT.com
Obama's dilemma over tax inversions
Jul 24 / FT.com
Top Stocks to Watch Today: St. Jude Medical, Abbott Laboratories, Eli Lilly, Pfizer
Jul 16 / MotleyFool.com
Eli Lilly Beats on Q2 Earnings & Revs, Maintains View - Analyst Blog
Jul 24 / Zacks.com
Lew: Stop firms moving abroad to dodge tax
Jul 16 / CNNMoney.com
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Jul 23 / MotleyFool.com
Jack Lew pushes Congress to crack down on tax 'inversions'
Jul 16 / FT.com
Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?
Jul 23 / MotleyFool.com
Why Is Wall Street Bullish on These 3 Stocks?
Jul 15 / MotleyFool.com
Puma Biotechnology Stock Shoves It in Short Sellers' Faces
Jul 23 / MotleyFool.com
Johnson & Johnson Beats on Q2 Earnings, Ups View Again - Analyst Blog
Jul 15 / Zacks.com
Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog
Jul 23 / Zacks.com
Why Kandi Technologies Shot Higher and Apollo Group Fell After Hours
Jul 14 / MotleyFool.com
Why Puma Biotechnology Inc Stock More Than Tripled Today
Jul 23 / MotleyFool.com
William Hague to step down as foreign secretary
Jul 14 / FT.com
Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog
Jul 23 / Zacks.com
Quindell starts on long road back to favour
Jul 14 / FT.com
Stock Market News for July 23, 2014 - Market News
Jul 23 / Zacks.com
Drug maker willing to pay more to escape U.S. tax
Jul 14 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.